217 related articles for article (PubMed ID: 8596537)
1. Effects of DNA topoisomerase inhibitors on nonhomologous and homologous recombination in mammalian cells.
Aratani Y; Andoh T; Koyama H
Mutat Res; 1996 Feb; 362(2):181-91. PubMed ID: 8596537
[TBL] [Abstract][Full Text] [Related]
2. Deletion and duplication sequences induced in CHO cells by teniposide (VM-26), a topoisomerase II targeting drug, can be explained by the processing of DNA nicks produced by the drug-topoisomerase interaction.
Ripley LS
Mutat Res; 1994 Apr; 312(2):67-78. PubMed ID: 7510833
[TBL] [Abstract][Full Text] [Related]
3. Chinese hamster ovary cells resistant to the topoisomerase II catalytic inhibitor ICRF-159: a Tyr49Phe mutation confers high-level resistance to bisdioxopiperazines.
Sehested M; Wessel I; Jensen LH; Holm B; Oliveri RS; Kenwrick S; Creighton AM; Nitiss JL; Jensen PB
Cancer Res; 1998 Apr; 58(7):1460-8. PubMed ID: 9537249
[TBL] [Abstract][Full Text] [Related]
4. RAD51 supports spontaneous non-homologous recombination in mammalian cells, but not the corresponding process induced by topoisomerase inhibitors.
Arnaudeau C; Rozier L; Cazaux C; Defais M; Jenssen D; Helleday T
Nucleic Acids Res; 2001 Feb; 29(3):662-7. PubMed ID: 11160887
[TBL] [Abstract][Full Text] [Related]
5. Camptothecin enhances random integration of transfected DNA into the genome of mammalian cells.
Shcherbakova OG; Filatov MV
Biochim Biophys Acta; 2000 Jan; 1495(1):1-3. PubMed ID: 10634926
[TBL] [Abstract][Full Text] [Related]
6. End extension repair of introduced targeting vectors mediated by homologous recombination in mammalian cells.
Aratani Y; Okazaki R; Koyama H
Nucleic Acids Res; 1992 Sep; 20(18):4795-801. PubMed ID: 1408793
[TBL] [Abstract][Full Text] [Related]
7. DNA topoisomerase II inhibitors enhance random integration of transfected vectors into human chromosomes.
Fujimaki K; Aratani Y; Fujisawa S; Motomura S; Okubo T; Koyama H
Somat Cell Mol Genet; 1996 Jul; 22(4):279-90. PubMed ID: 9000172
[TBL] [Abstract][Full Text] [Related]
8. Hypersensitivity of nonhomologous DNA end-joining mutants to VP-16 and ICRF-193: implications for the repair of topoisomerase II-mediated DNA damage.
Adachi N; Suzuki H; Iiizumi S; Koyama H
J Biol Chem; 2003 Sep; 278(38):35897-902. PubMed ID: 12842886
[TBL] [Abstract][Full Text] [Related]
9. Inactivation of topoisomerase I or II may lead to recombination or to aberrant replication termination on both SV40 and yeast 2 micron DNA.
Levac P; Moss T
Chromosoma; 1996 Oct; 105(4):250-60. PubMed ID: 8854885
[TBL] [Abstract][Full Text] [Related]
10. Targeted homologous recombination at the endogenous adenine phosphoribosyltransferase locus in Chinese hamster cells.
Adair GM; Nairn RS; Wilson JH; Seidman MM; Brotherman KA; MacKinnon C; Scheerer JB
Proc Natl Acad Sci U S A; 1989 Jun; 86(12):4574-8. PubMed ID: 2734308
[TBL] [Abstract][Full Text] [Related]
11. Altered topoisomerase I activity and recombination activating gene expression in a human leukemia cell line resistant to doxorubicin.
Riou JF; Grondard L; Petitgenet O; Abitbol M; Lavelle F
Biochem Pharmacol; 1993 Sep; 46(5):851-61. PubMed ID: 8396937
[TBL] [Abstract][Full Text] [Related]
12. International Commission for Protection Against Environmental Mutagens and Carcinogens. Mutagenicity and carcinogenicity of topoisomerase-interactive agents.
Anderson RD; Berger NA
Mutat Res; 1994 Aug; 309(1):109-42. PubMed ID: 7519727
[TBL] [Abstract][Full Text] [Related]
13. Homologous recombination is a highly conserved determinant of the synergistic cytotoxicity between cisplatin and DNA topoisomerase I poisons.
van Waardenburg RC; de Jong LA; van Delft F; van Eijndhoven MA; Bohlander M; Bjornsti MA; Brouwer J; Schellens JH
Mol Cancer Ther; 2004 Apr; 3(4):393-402. PubMed ID: 15078982
[TBL] [Abstract][Full Text] [Related]
14. Effect of vector topology on homologous recombination at the CHO aprt locus.
Ward MA; Abramow-Newerly W; Roder JC
Somat Cell Mol Genet; 1993 May; 19(3):257-64. PubMed ID: 8332933
[TBL] [Abstract][Full Text] [Related]
15. Studies on the role of topoisomerases in general, gene- and strand-specific DNA repair.
Stevnsner T; Bohr VA
Carcinogenesis; 1993 Sep; 14(9):1841-50. PubMed ID: 8403208
[TBL] [Abstract][Full Text] [Related]
16. The role of the DNA mismatch repair system in the cytotoxicity of the topoisomerase inhibitors camptothecin and etoposide to human colorectal cancer cells.
Jacob S; Aguado M; Fallik D; Praz F
Cancer Res; 2001 Sep; 61(17):6555-62. PubMed ID: 11522654
[TBL] [Abstract][Full Text] [Related]
17. Cytogenetic effects of inhibition of topoisomerase I or II activities in the CHO mutant EM9 and its parental line AA8.
Cortés F; Piñero J; Palitti F
Mutat Res; 1993 Aug; 288(2):281-9. PubMed ID: 7688089
[TBL] [Abstract][Full Text] [Related]
18. Probing the interaction of the cytotoxic bisdioxopiperazine ICRF-193 with the closed enzyme clamp of human topoisomerase IIalpha.
Patel S; Jazrawi E; Creighton AM; Austin CA; Fisher LM
Mol Pharmacol; 2000 Sep; 58(3):560-8. PubMed ID: 10953049
[TBL] [Abstract][Full Text] [Related]
19. Genotoxic profile of inhibitors of topoisomerases I (camptothecin) and II (etoposide) in a mitotic recombination and sex-chromosome loss somatic eye assay of Drosophila melanogaster.
Sortibrán AN; Téllez MG; Rodríguez-Arnaiz R
Mutat Res; 2006 Apr; 604(1-2):83-90. PubMed ID: 16529987
[TBL] [Abstract][Full Text] [Related]
20. Various inhibitors of DNA topoisomerases diminish repair-specific DNA incision in UV-irradiated human fibroblasts.
Thielmann HW; Popanda O; Gersbach H; Gilberg F
Carcinogenesis; 1993 Nov; 14(11):2341-51. PubMed ID: 8242865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
